LENZ Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-8.7M | $-10.3M | $1.5M | $177.0K |
| FY2021 | $-52.9M | $-58.6M | $5.7M | $7.9M |
| FY2022 | $-88.0M | $-94.6M | $6.6M | $13.5M |
| FY2023 | $-60.4M | $-60.4M | $30.0K | $1.3M |
| FY2024 | $-59.4M | $-59.9M | $468.0K | $6.4M |